Delivery Order SPE2DR25D3501-SPE2DR26FM2DF
- Not listed
- The Defense Logistics Agency awarded a $5,351.66 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The contract is scheduled for completion by January 12, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was awarded on a non-competitive basis as a child order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $9,685.88 to AmerSourceBergen Drug Corp for Phytonadione 1 mg/0.5 ml syringes. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by January 7, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,026.32 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of October 24, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Phytonadione is a synthetic form of...
- The Defense Logistics Agency awarded a $10,741.92 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes, with a contract ceiling value of $36,199.94 and a completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical distributor supporting federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed-price delivery order, valued at $4,843.91, represents a non-competitive set-aside and is scheduled for completion by October 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, also known as vitamin K1, is a critical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,308.92 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on September 17, 2025, with completion targeted for September 18, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded a $2,132.69 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used to treat vitamin K...
- The Defense Logistics Agency awarded a delivery order valued at $10,492.26 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This contract, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as vitamin K1,...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2DFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,493.60 to AmerSourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL unit doses. This contract was competitively awarded with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 13, 2026. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as the company's corporate office and primary distribution hub. This delivery order represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2031. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support across military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Phytonadione, a vitamin K1 product used for coagulation disorders and bleeding prevention, falls within the scope of critical medications required by military treatment facilities and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 1/11/26 |